Aligos Therapeutics (ALGS) Stock: Buy, Sell, or Hold?
ALGS - Aligos Therapeutics, Inc. Common Stock
$5.54
0.04 (0.73%)
â˛
5d:
+0.54%
30d:
-10.79%
90d:
-5.3%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When ALGS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ALGS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ALGS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: ALGS is currently trading at $5.54, which is considered fair relative to its 30-day fair value range of $5.12 to $6.48.
Technical Outlook: Technically, ALGS is showing sideways momentum. Immediate support is located at $5.18, while resistance sits at $6.30.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $52.38 (+845.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALGS is showing sideways momentum. Immediate support is located at $5.18, while resistance sits at $6.30.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $52.38 (+845.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$5.12 -
$6.48
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (42/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 845.4% below Wall St target ($52.38)
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$5.12 -
$6.48
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$5.18
Resistance Level
$6.30
Current Trend
Sideways
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.06
Wall Street Target
$52.38
(+845.4%)
Revenue Growth (YoY)
2778.5%
Profit Margin
-241.0%
Share & Embed Analysis
Last updated: October 03, 2026 4:38 AM ET
Data refreshes hourly during market hours. Next update: 5:38 AM
Data refreshes hourly during market hours. Next update: 5:38 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALGS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$75 | 60 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$28 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 58 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$95 | 57 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$52 | 66 BUY |
